YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
BALA CYNWYD, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Acker…
(RTTNews) - Today's top biotech gainers include SciSparc, after its subsidiary successfully completed internal validation of a proprietary quantum sampling platform designed to analyze clinical trial data; Avantor, following the release of…
Key Points Interested in MiMedx Group, Inc? Here are five stocks we like better. MiMedx agreed to acquire Sanara MedTech for $35 per share, adding more than $100 million in surgical revenue and approximately $4 billion in addressable marke…
Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET MARIETTA, Ga., Ju…
Issued on behalf of Conexeu Sciences Inc. A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in. NEW YORK, June 1…
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQ: MDXG). Such investors are advised to contact Danielle Peyton at newaction@po…
MiMedx Group Inc. (NASDAQ:MDXG) is one of the best biotech penny stocks to buy in 2026. On March 23, MiMedx officially announced the commercial launch of CHORIOFIX, the latest addition to its portfolio of advanced placental allografts. Thi…
Earnings Call Insights: MiMedx Group (MDXG) Q1 2026 MANAGEMENT VIEW * “The start of the year has been an eventful one for MiMedx as we navigated the new reimbursement dynamics and continue to leverage growth opportunities for the company,”…
MiMedx Group logo Key Points MiMedx reported Q1 consolidated net sales of $59 million (down 33% y/y) with surgical sales rising to $36 million (+13%) while wound care plunged to $23 million (-60%), producing a GAAP net loss of $11 million.…
MiMedx Group Inc. (NASDAQ:MDXG) is one of the 10 oversold small cap stocks to buy now. On April 17, Northland reduced the price target on MiMedx Group Inc. (NASDAQ:MDXG) from $10 to $6, which still results in an adjusted upside of more tha…
We recently compiled a list of the 9 Most Undervalued Healthcare Stocks to Buy Now. MiMedx Group, Inc. is among the most undervalued stocks. TheFly reported on April 20 that Citizens Financial Group lowered its price target on MDXG from $1…
[Stock Exchange] ShinjiPhotographer Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - APRIL 20 * VOL…
(RTTNews) - MiMedx Group, Inc. (MDXG) Thursday announced elimination of the position of Chief Operating Officer, held by Ricci Whitlow and a series of cost reduction plans to save approximately $40 million. Further, the company now project…
[Man looking at currency trading app on his smart phone from his home office] Alistair Berg A notable shift is underway in the small-cap market in 2026: profitable Russell 2000 companies are decisively outperforming their non-profitable co…
MiMedx Group, Inc. (NASDAQ:MDXG) is one of the Best 52-Week Low Penny Stocks to Invest In. On February 25, MiMedx Group, Inc. (NASDAQ:MDXG) delivered record quarterly and full-year revenue and profitability. This was driven by the company…
Earnings Call Insights: MiMedx Group, Inc. (MDXG) Q4 2025 MANAGEMENT VIEW * CEO Joseph Capper stated, "In the fourth quarter of 2025, we once again exceeded our expectations, setting full year record highs for revenue and adjusted EBITDA,…
Image source: The Motley Fool. DATE Feb. 25, 2026, 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Joseph H. Capper Chief Financial Officer — Douglas C. Rice Vice President, Investor Relations — Matthew Notarianni Full Conference…
Company Logo Technological advances and growing investments in stem cell research by private entities and governments enhance therapeutic production while reducing costs, fueling market growth and adoption Stem Cell and Regenerative Therap…
We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. MiMedx Group, Inc. (NASDAQ:MDXG) is on our list of best biotech stocks. TheFly reported on January 23 that Craig-Hallum analyst Chase Knickerbocker lowered the…
[CMS] gustavofrazao Organogenesis (ORGO [https://seekingalpha.com/symbol/ORGO]) and MiMedx (MDXG [https://seekingalpha.com/symbol/MDXG]) traded lower on Friday after the Centers for Medicare & Medicaid Services (CMS) announced the withdraw…
Company Logo In 2023, the global wound care market was valued at US$22.06 billion, projected to reach US$30.01 billion by 2029, growing at a CAGR of 5.26%. This growth is driven by advancements in wound care technologies, increasing elderl…
As of November 6, 2025, the United States market has been experiencing volatility with major stock indexes like the Nasdaq and S&P 500 closing lower due to resurfacing concerns about AI valuations and a significant uptick in job cuts repor…
MARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of the CY 2026 Physician Fee Schedule (“PFS”)…
Earnings Call Insights: MiMedx Group, Inc. (MDXG) Q3 2025 MANAGEMENT VIEW * CEO Joseph Capper reported "our third quarter performance was outstanding across the enterprise, generating strong top line growth in both our Wound and Surgical f…
(RTTNews) - MiMedx Group Inc. (MDXG) revealed earnings for its third quarter that Increases, from last year The company's bottom line totaled $16.74 million, or $0.11 per share. This compares with $8.09 million, or $0.05 per share, last ye…
Second Consecutive Quarter of Highest Quarterly Net Sales in MIMEDX History Third Quarter Net Sales of $114 million Grew 35% Year-Over-Year Third Quarter GAAP Net Income and Diluted Earnings Per Share were $17 Million and $0.11, Respective…
MARIETTA, Ga., Oct. 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2025 after the…
MARIETTA, Ga., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the launch of EPIXPRESS®, the Company’s newest addition to its portfolio of AWC solutions. “I am pleased to anno…
As major U.S. stock indexes recently closed higher, rebounding from a losing week amid concerns over a potential government shutdown, the tech-heavy Nasdaq showed resilience with a 0.5% gain. In this context of market volatility and econom…
MARIETTA, Ga., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced its schedule for the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place September 3-6 in Las Veg…
As the U.S. market navigates a period of retreat from record highs, with tech stocks experiencing notable declines, investors are closely monitoring key indices like the S&P 500 and Dow Jones Industrial Average for signs of broader economi…
We recently published 10 Best Biotech Stocks to Buy Under $10.MiMedx Group, Inc. is placed sixth among them. MiMedx Group, Inc. (NASDAQ:MDXG) is a biotechnology company based in Marietta, Georgia, specializing in regenerative biologics for…
MARIETTA, Ga., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Cantor Global Heal…
As of July 2025, the U.S. stock market has experienced a mixed performance with major indices like the S&P 500 and Nasdaq reaching record highs earlier in the month, despite recent declines amid fluctuating investor sentiment driven by tec…
In trading on Thursday, shares of MiMedx Group Inc (Symbol: MDXG) crossed above their 200 day moving average of $7.56, changing hands as high as $7.99 per share. MiMedx Group Inc shares are currently trading up about 15.5% on the day. The…
Release Date: July 30, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points TTM Technologies Inc (NASDAQ:TTMI) achieved a 21% year-on-year revenue growth, driven by stron…